Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 228

1.

Salt-Treated Roots of Oryza australiensis Seedlings are Enriched with Proteins Involved in Energetics and Transport.

Yichie Y, Hasan MT, Tobias PA, Pascovici D, Goold HD, Van Sluyter SC, Roberts TH, Atwell BJ.

Proteomics. 2019 Oct;19(19):e1900175. doi: 10.1002/pmic.201900175.

PMID:
31475433
2.

Sustained Release of Hydrogen Sulfide (H2S) from Poly(Lactic Acid) Functionalized 4-Hydroxythiobenzamide Microparticles to Protect Against Oxidative Damage.

Do AV, Smith R, Tobias P, Carlsen D, Pham E, Bowden NB, Salem AK.

Ann Biomed Eng. 2019 Aug;47(8):1691-1700. doi: 10.1007/s10439-019-02270-9. Epub 2019 May 28.

PMID:
31139973
3.

Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman Primates.

Tobias P, Philipp SI, Stylianos M, Martin B, Barbara W, Felix R, Alexander OG, Eberhart Z, Marius U, Birgit K, Sven K, Ulrich BK, Dominik FM; RD-Cure Consortium.

Hum Gene Ther Clin Dev. 2019 Jun;30(2):50-56. doi: 10.1089/humc.2018.188.

PMID:
30864850
4.

A Case of Linezolid Induced Toxicity.

Tobias PE, Varughese CA, Hanson AP, Gurnani PK.

J Pharm Pract. 2018 Jan 1:897190018782787. doi: 10.1177/0897190018782787. [Epub ahead of print]

PMID:
29911459
5.

Prediction of post-acute care demand in medical and neurological inpatients: diagnostic assessment of the post-acute discharge score - a prospective cohort study.

Conca A, Gabele A, Reutlinger B, Schuetz P, Kutz A, Haubitz S, Faessler L, Batschwaroff M, Schild U, Caldara Z, Regez K, Schirlo S, Vossler G, Kahles T, Nedeltchev K, Keller A, Huber A, De Geest S, Buergi U, Tobias P, Louis Simonet M, Mueller B, Schäfer-Keller P.

BMC Health Serv Res. 2018 Feb 13;18(1):111. doi: 10.1186/s12913-018-2897-0.

6.

Combining ultrasound and intratumoral administration of doxorubicin-loaded microspheres to enhance tumor cell killing.

Do AV, Geary SM, Seol D, Tobias P, Carlsen D, Leelakanok N, Martin JA, Salem AK.

Int J Pharm. 2018 Mar 25;539(1-2):139-146. doi: 10.1016/j.ijpharm.2018.01.028. Epub 2018 Jan 17.

7.

De Novo Transcriptome Study Identifies Candidate Genes Involved in Resistance to Austropuccinia psidii (Myrtle Rust) in Syzygium luehmannii (Riberry).

Tobias PA, Guest DI, Külheim C, Park RF.

Phytopathology. 2018 May;108(5):627-640. doi: 10.1094/PHYTO-09-17-0298-R. Epub 2018 Mar 19.

PMID:
29231777
8.

Identification of the Eucalyptus grandis chitinase gene family and expression characterization under different biotic stress challenges.

Tobias PA, Christie N, Naidoo S, Guest DI, Külheim C.

Tree Physiol. 2017 May 1;37(5):565-582. doi: 10.1093/treephys/tpx010.

PMID:
28338992
9.

The Eucalyptus grandis NBS-LRR Gene Family: Physical Clustering and Expression Hotspots.

Christie N, Tobias PA, Naidoo S, Külheim C.

Front Plant Sci. 2016 Jan 12;6:1238. doi: 10.3389/fpls.2015.01238. eCollection 2015.

10.

A curious case of resistance to a new encounter pathogen: myrtle rust in Australia.

Tobias PA, Guest DI, Külheim C, Hsieh JF, Park RF.

Mol Plant Pathol. 2016 Jun;17(5):783-8. doi: 10.1111/mpp.12331. Epub 2016 Mar 22. Review.

11.

Performance of the Manchester Triage System in Adult Medical Emergency Patients: A Prospective Cohort Study.

Steiner D, Renetseder F, Kutz A, Haubitz S, Faessler L, Anderson JB, Laukemann S, Rast AC, Felder S, Conca A, Reutlinger B, Batschwaroff M, Tobias P, Buergi U, Mueller B, Schuetz P.

J Emerg Med. 2016 Apr;50(4):678-89. doi: 10.1016/j.jemermed.2015.09.008. Epub 2015 Oct 14.

PMID:
26458788
12.

Statistical Characteristics of Wrong-Way Driving Crashes on Illinois Freeways.

Zhou H, Zhao J, Pour-Rouholamin M, Tobias PA.

Traffic Inj Prev. 2015;16(8):760-7. doi: 10.1080/15389588.2015.1020421. Epub 2015 Mar 20.

PMID:
25793548
13.

Intrapartum ultrasound prior to Kristeller maneuver: an observational study.

Cuerva MJ, Tobias P, Espinosa JA, Bartha JL.

J Perinat Med. 2015 Mar;43(2):171-5.

PMID:
25032803
14.

Tree immunity: growing old without antibodies.

Tobias PA, Guest DI.

Trends Plant Sci. 2014 Jun;19(6):367-70. doi: 10.1016/j.tplants.2014.01.011. Epub 2014 Feb 18.

PMID:
24556378
15.

Significance of using DICOM communication standard in quality assurance in radiation oncology - an institutional experience.

Tobias P, Vrana D, Cwiertka K, Gremlica D, Slampa P.

J BUON. 2013 Oct-Dec;18(4):1045-7.

16.

Use of intrapartum ultrasound in the prediction of complicated operative forceps delivery of fetuses in non-occiput posterior position.

Cuerva MJ, Bamberg C, Tobias P, Gil MM, De La Calle M, Bartha JL.

Ultrasound Obstet Gynecol. 2014 Jun;43(6):687-92. doi: 10.1002/uog.13256.

17.

The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation.

Ma J, Bang BR, Lu J, Eun SY, Otsuka M, Croft M, Tobias P, Han J, Takeuchi O, Akira S, Karin M, Yagita H, Kang YJ.

Sci Signal. 2013 Oct 1;6(295):ra87. doi: 10.1126/scisignal.2004431.

18.

A potential suppressive effect of natural antisense IL-1β RNA on lipopolysaccharide-induced IL-1β expression.

Lu J, Wu X, Hong M, Tobias P, Han J.

J Immunol. 2013 Jun 15;190(12):6570-8. doi: 10.4049/jimmunol.1102487. Epub 2013 May 15.

19.

[At admission planning discharge already].

Conca A, Regez K, Schild U, Reutlinger B, Schäfer P, Schweingruber R, Tobias P, Bürgi U, Schirlo S, Müller B, Albrich WC.

Krankenpfl Soins Infirm. 2013;106(1):20-3. German. No abstract available.

PMID:
23405447
20.

The Savannah hypotheses: origin, reception and impact on paleoanthropology.

Bender R, Tobias PV, Bender N.

Hist Philos Life Sci. 2012;34(1-2):147-84.

PMID:
23272598
21.

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists.

Curtiss LK, Black AS, Bonnet DJ, Tobias PS.

J Lipid Res. 2012 Oct;53(10):2126-32. doi: 10.1194/jlr.M028431. Epub 2012 Jul 20.

22.

The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice.

Richards MR, Black AS, Bonnet DJ, Barish GD, Woo CW, Tabas I, Curtiss LK, Tobias PS.

Innate Immun. 2013 Feb;19(1):20-9. doi: 10.1177/1753425912447130. Epub 2012 May 25.

23.

The use of small molecule probes to study spatially separated stimulus-induced signaling pathways.

Kravchenko VV, Gloeckner C, Stowe GN, Kang YJ, Tobias PS, Mathison JC, Ulevitch RJ, Kaufmann GF, Janda KD.

Bioorg Med Chem Lett. 2012 Mar 1;22(5):2043-5. doi: 10.1016/j.bmcl.2012.01.024. Epub 2012 Jan 14.

24.

Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.

Owens AP 3rd, Passam FH, Antoniak S, Marshall SM, McDaniel AL, Rudel L, Williams JC, Hubbard BK, Dutton JA, Wang J, Tobias PS, Curtiss LK, Daugherty A, Kirchhofer D, Luyendyk JP, Moriarty PM, Nagarajan S, Furie BC, Furie B, Johns DG, Temel RE, Mackman N.

J Clin Invest. 2012 Feb;122(2):558-68. doi: 10.1172/JCI58969. Epub 2012 Jan 3.

25.

MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.

Owens AP 3rd, Rateri DL, Howatt DA, Moore KJ, Tobias PS, Curtiss LK, Lu H, Cassis LA, Daugherty A.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2813-9. doi: 10.1161/ATVBAHA.111.238642. Epub 2011 Sep 29.

26.

[Radiotherapy and the flow of data and documentation].

Tobiás P, Slampa PR, Zychácek M.

Klin Onkol. 2011;24(3):224-30. Czech.

PMID:
21717793
27.

Knockout of toll-like receptor-2 attenuates both the proinflammatory state of diabetes and incipient diabetic nephropathy.

Devaraj S, Tobias P, Kasinath BS, Ramsamooj R, Afify A, Jialal I.

Arterioscler Thromb Vasc Biol. 2011 Aug;31(8):1796-804. doi: 10.1161/ATVBAHA.111.228924. Epub 2011 May 26.

28.

Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.

Devaraj S, Tobias P, Jialal I.

Cytokine. 2011 Sep;55(3):441-5. doi: 10.1016/j.cyto.2011.03.023. Epub 2011 Apr 16. Erratum in: Cytokine. 2011 Dec;56(3):832.

PMID:
21498084
29.

Epithelial p38alpha controls immune cell recruitment in the colonic mucosa.

Kang YJ, Otsuka M, van den Berg A, Hong L, Huang Z, Wu X, Zhang DW, Vallance BA, Tobias PS, Han J.

PLoS Pathog. 2010 Jun 3;6(6):e1000934. doi: 10.1371/journal.ppat.1000934.

30.

Morphometric variations of the 7th cervical vertebrae of Zulu, White, and Colored South Africans.

Kibii JM, Pan R, Tobias PV.

Clin Anat. 2010 May;23(4):399-406. doi: 10.1002/ca.20962.

PMID:
20235180
31.

Emerging role of Toll-like receptors in atherosclerosis.

Curtiss LK, Tobias PS.

J Lipid Res. 2009 Apr;50 Suppl:S340-5. doi: 10.1194/jlr.R800056-JLR200. Epub 2008 Nov 1. Review.

32.

Raymond Dart as a pioneering primatologist.

Strkalj G, Tobias PV.

Homo. 2008;59(4):271-86. doi: 10.1016/j.jchb.2008.06.002. Epub 2008 Aug 3.

PMID:
18675977
33.

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events.

Mullick AE, Soldau K, Kiosses WB, Bell TA 3rd, Tobias PS, Curtiss LK.

J Exp Med. 2008 Feb 18;205(2):373-83. doi: 10.1084/jem.20071096. Epub 2008 Feb 4.

34.

The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.

Curtiss LK, Tobias PS.

Curr Drug Targets. 2007 Dec;8(12):1230-8. Review.

PMID:
18220700
35.

TLRs in disease.

Tobias PS.

Semin Immunopathol. 2008 Feb;30(1):1-2. doi: 10.1007/s00281-007-0104-1. No abstract available.

PMID:
18200446
36.

TLR2 in murine atherosclerosis.

Tobias PS, Curtiss LK.

Semin Immunopathol. 2008 Feb;30(1):23-7. Epub 2007 Dec 6. Review.

PMID:
18058099
37.

Toll-like receptors in atherosclerosis.

Tobias PS, Curtiss LK.

Biochem Soc Trans. 2007 Dec;35(Pt 6):1453-5. Review.

PMID:
18031244
38.

Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors.

Lee HK, Brown SJ, Rosen H, Tobias PS.

Mol Pharmacol. 2007 Oct;72(4):868-75. Epub 2007 Jul 5.

PMID:
17615244
39.

Retrospective: Francis Clark Howell (1925-2007).

Tobias PV.

Science. 2007 May 18;316(5827):995. No abstract available.

PMID:
17510355
40.

TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways.

Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB.

J Immunol. 2007 May 15;178(10):6252-8.

41.

Bone breccias, bone dumps, and sedimentary sequences of the western Limeworks, Makapansgat, South Africa.

Latham AG, McKee JK, Tobias PV.

J Hum Evol. 2007 Apr;52(4):388-400. Epub 2006 Nov 14.

PMID:
17196239
42.

Toll-like receptors and atherosclerosis: key contributors in disease and health?

Mullick AE, Tobias PS, Curtiss LK.

Immunol Res. 2006;34(3):193-209. Review.

PMID:
16891671
43.

TLR2 is required for the altered transcription of p75NGF receptors in gram positive infection.

Wirz SA, Tobias PS, Ulevitch RJ, Aribibe L, Bartfai T.

Neurochem Res. 2006 Feb;31(2):297-301. Epub 2006 Mar 3.

PMID:
16518575
44.

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

Lee HK, Dunzendorfer S, Soldau K, Tobias PS.

Immunity. 2006 Feb;24(2):153-63.

45.

Mutational analysis of membrane and soluble forms of human MD-2.

Viriyakosol S, Tobias PS, Kirkland TN.

J Biol Chem. 2006 Apr 28;281(17):11955-64. Epub 2006 Feb 8.

48.

Modulation of atherosclerosis in mice by Toll-like receptor 2.

Mullick AE, Tobias PS, Curtiss LK.

J Clin Invest. 2005 Nov;115(11):3149-56. Epub 2005 Oct 6.

49.
50.

Supplemental Content

Loading ...
Support Center